retatrutide triple agonist obesity trial hormone receptor for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a retatrutide phase 2 trial obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




























